Krystal Biotech, Inc.
US ˙ NasdaqGS ˙ US5011471027

SecurityKRYS / Krystal Biotech, Inc.
InstitutionKBC Group NV
Latest Disclosed Ownership685 shares
Latest Disclosed Value $ 177
KBC Group NV ownership in KRYS / Krystal Biotech, Inc.

On May 7, 2026 - KBC Group NV filed a 13F-HR form disclosing ownership of 685 shares of Krystal Biotech, Inc. (US:KRYS) valued at $176,949 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 685 shares of Krystal Biotech, Inc.. The current value of the position is $206,747 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 685 0 0.00 0 0.0002
2026-01-26 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 685 0 0.00 0 0.0004
2026-01-20 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 685 0 0.00 0 0.0003
2025-08-08 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 685 -254 -27.05 0 0.0003
2025-04-25 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 939 0 0.00 0 0.0005
2025-01-22 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 939 297 46.26 0 0.0004
2024-11-06 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 642 132 25.88 0 0.0004
2024-07-17 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 510 37 7.82 0 0.0003
2024-05-08 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 473 0 0.00 0 0.0003
2024-02-13 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 473 0 0.00 0 0.0002
2024-02-15 2023-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 473 473 0 0.0002
2024-02-14 2021-12-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 0 -1,975 -100.00 0 -100.00
2022-02-03 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 0 -1,975 0
2021-11-10 2021-09-30 13F KRYSTAL BIOTECH COM 501147102 1,975 0 0.00 103 -23.13 0.0004
2022-02-15 2021-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,975 0 0.00 134 -11.84 0.0005
2021-08-11 2021-06-30 13F KRYSTAL BIOTECH COM 501147102 1,975 0 134 0.0005
2022-02-14 2021-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,975 0 0.00 152 -87.17 0.0006
2021-04-26 2021-03-31 13F KRYSTAL BIOTECH COM 501147102 1,975 0 152 0.0006
2022-02-14 2020-12-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,975 0 0.00 1,185 1,294.12 0.0006
2021-02-10 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 1,975 0 119 0.0005
2022-02-14 2020-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,975 0 0.00 85 3.66 0.0005
2020-10-28 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 1,975 0 85 0.0005
2022-02-14 2020-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 1,975 1,600 426.67 82 412.50 0.0005
2020-08-10 2020-06-30 13F KRYSTAL BIOTECH COM 501147102 1,975 1,600 82 0.0005
2020-05-04 2020-03-31 13F KRYSTAL BIOTECH COM 501147102 375 0 0.00 16 -23.81 0.0001
2020-02-11 2019-12-31 13F KRYSTAL BIOTECH COM 501147102 375 -5,390 -93.50 21 -89.50 0.0001
2019-11-07 2019-09-30 13F KRYSTAL BIOTECH COM 501147102 5,765 2,490 76.03 200 51.52 0.0015
2019-12-03 2019-06-30 13F/A-2 KRYSTAL BIOTECH COM 501147102 3,275 0 0.00 132 22.22 1.1467
2019-12-03 2019-03-31 13F/A-2 KRYSTAL BIOTECH COM 501147102 3,275 350 11.97 108 77.05 0.9816
2019-12-03 2018-12-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,925 700 31.46 61 56.41 0.7125
2019-12-03 2018-09-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,225 0 0.00 39 18.18 0.3848
2019-12-03 2018-06-30 13F/A-1 KRYSTAL BIOTECH COM 501147102 2,225 0 0.00 33 50.00 0.3645
2019-12-03 2018-03-31 13F/A-2 KRYSTAL BIOTECH COM 501147102 2,225 1,225 122.50 22 100.00 0.2345
2019-12-03 2017-12-31 13F/A-2 KRYSTAL BIOTECH COM 501147102 1,000 1,000 11 0.1173
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.